Cognos Therapeutics
Cognos Therapeutics8About
What does Cognos Therapeutics do?
Cognos Therapeutics is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic approach for neurodegenerative diseases. Their lead product candidate, CG-001, is designed to target the underlying pathology of diseases such as Alzheimer's and Parkinson's. The company aims to bring a disease-modifying therapy to patients who currently have limited treatment options.
Where is Cognos Therapeutics headquartered?
Cognos Therapeutics is headquartered in Tel Aviv, Israel.
What industry does Cognos Therapeutics operate in?
Cognos Therapeutics operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Neurotech.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.